Offshore
Photo
InsideArbitrage
Revance $RVNC Board to Explore Teoxane’s Offer Despite Crown’s Push for Merger -
In response to Teoxane's proposal to acquire Revance, Crown described the offer as "clearly inferior" to the existing merger agreement between Crown and Revance. Crown stated that it expects the merger with Revance to close as early as next week and urged Revance's Board to promptly reject the Teoxane Proposal.
On the morning of January 7, 2025, Revance’s Board held a meeting to review and evaluate the Teoxane Proposal. After thorough discussion, the Board unanimously determined that the Teoxane proposal had the potential to qualify as a “Superior Proposal” under the terms of the merger agreement. The Board also resolved to proceed with discussions and negotiations with Teoxane.
tweet
Revance $RVNC Board to Explore Teoxane’s Offer Despite Crown’s Push for Merger -
In response to Teoxane's proposal to acquire Revance, Crown described the offer as "clearly inferior" to the existing merger agreement between Crown and Revance. Crown stated that it expects the merger with Revance to close as early as next week and urged Revance's Board to promptly reject the Teoxane Proposal.
On the morning of January 7, 2025, Revance’s Board held a meeting to review and evaluate the Teoxane Proposal. After thorough discussion, the Board unanimously determined that the Teoxane proposal had the potential to qualify as a “Superior Proposal” under the terms of the merger agreement. The Board also resolved to proceed with discussions and negotiations with Teoxane.
Teoxane SA, a swiss medical aesthetics company has proposed to acquire Revance Therapeutics, Inc. $RVNC, for $3.60 per share in cash.
This offer, announced today, represents a 16% premium over the price set in Revance's amended agreement with Crown Laboratories, which was $3.10 per share. tweet
Offshore
Photo
InsideArbitrage
UK's CMA to consider undertakings offered by Ansys $ANSS and Synopsys $SNPS -
@CMAgovUK announced that it will review undertakings proposed by Ansys and Synopsys. The companies have offered to divest certain parts of their businesses to address the CMA’s concerns. The CMA believes there are reasonable grounds to think that these undertakings, or a modified version of them, could be accepted.
Synopsys, in response, added that it is "very pleased that the CMA has taken the important step of provisionally accepting our proposed remedies in Phase 1 rather than referring the transaction to Phase 2."
The companies expect the deal to close in the first half of 2025.
tweet
UK's CMA to consider undertakings offered by Ansys $ANSS and Synopsys $SNPS -
@CMAgovUK announced that it will review undertakings proposed by Ansys and Synopsys. The companies have offered to divest certain parts of their businesses to address the CMA’s concerns. The CMA believes there are reasonable grounds to think that these undertakings, or a modified version of them, could be accepted.
Synopsys, in response, added that it is "very pleased that the CMA has taken the important step of provisionally accepting our proposed remedies in Phase 1 rather than referring the transaction to Phase 2."
The companies expect the deal to close in the first half of 2025.
tweet
Offshore
Video
Startup Archive
Paul Graham explains his rule of thumb for when to launch your product
“The risk of launching early is not as great as the risk of launching late… So you’ve got to have a good rule of thumb about when to launch. And my rule of thumb is launch as soon as you have a quantum of utility, which means as soon as there’s one person in the world who is glad you launched because now they can do something that they couldn’t do.”
He continues:
“If you have something that if you launched it, no one would be happy, then you’re not ready to launch… [But] if there’s 10 people who are super excited and nobody else cares, totally launch. That’s perfectly fine. That’s great.”
Video source: @ycombinator (2018)
tweet
Paul Graham explains his rule of thumb for when to launch your product
“The risk of launching early is not as great as the risk of launching late… So you’ve got to have a good rule of thumb about when to launch. And my rule of thumb is launch as soon as you have a quantum of utility, which means as soon as there’s one person in the world who is glad you launched because now they can do something that they couldn’t do.”
He continues:
“If you have something that if you launched it, no one would be happy, then you’re not ready to launch… [But] if there’s 10 people who are super excited and nobody else cares, totally launch. That’s perfectly fine. That’s great.”
Video source: @ycombinator (2018)
tweet
Offshore
Photo
Stock Analysis Compilation
Alluvial on Bahnhof AB $BAHNB SS
Thesis: Bahnhof AB is a highly efficient Swedish internet service provider with impressive revenue growth and negative working capital that supports its investment needs.
(Extract from their Q3 letter) https://t.co/8EUQ0esuoG
tweet
Alluvial on Bahnhof AB $BAHNB SS
Thesis: Bahnhof AB is a highly efficient Swedish internet service provider with impressive revenue growth and negative working capital that supports its investment needs.
(Extract from their Q3 letter) https://t.co/8EUQ0esuoG
tweet
Offshore
Photo
Offshore
Photo
InsideArbitrage
The InsideArbitrage Buyback Wednesdays is out!
"Dave & Buster’s Spins the Wheel With a $100 Million Stock Repurchase"
👉 Full Article link in the final tweet!
🧵1/n https://t.co/58bXRgD56j
tweet
The InsideArbitrage Buyback Wednesdays is out!
"Dave & Buster’s Spins the Wheel With a $100 Million Stock Repurchase"
👉 Full Article link in the final tweet!
🧵1/n https://t.co/58bXRgD56j
tweet
Hidden Value Gems
Will EU sanction US businessmen and freeze US assets in Europe ? 🤔
tweet
Will EU sanction US businessmen and freeze US assets in Europe ? 🤔
JUST IN - European Union will "not tolerate" a takeover of Greenland by the United States: France warned Trump against threatening the bloc's "sovereign borders" — Telegraph tweet
twitter.com
undefined
undefined
Offshore
Photo
Quiver Quantitative
RT @QuiverCongress: JUST IN: Representative David Schweikert just introduced legislation to let authorized AI models prescribe drugs.
Follow here for updates. https://t.co/bjrDgI7Zez
tweet
RT @QuiverCongress: JUST IN: Representative David Schweikert just introduced legislation to let authorized AI models prescribe drugs.
Follow here for updates. https://t.co/bjrDgI7Zez
tweet
Offshore
Photo
Investing visuals
Palantir $PLTR quarterly revenue per employee is $192.000 as of Q3 '24 and the highest it's ever been.
That's $768.000 on a yearly basis🤯 https://t.co/C2uuzQA8ag
tweet
Palantir $PLTR quarterly revenue per employee is $192.000 as of Q3 '24 and the highest it's ever been.
That's $768.000 on a yearly basis🤯 https://t.co/C2uuzQA8ag
tweet
Offshore
Photo
Quiver Quantitative
JUST IN: Representative Virginia Foxx just disclosed a sale of up to $100K of stock in Pembina Pipeline, $PBA.
$PBA is a Canadian pipeline company.
Probably bearish for trade between the US and Canada. https://t.co/wGXkoGFrQw
tweet
JUST IN: Representative Virginia Foxx just disclosed a sale of up to $100K of stock in Pembina Pipeline, $PBA.
$PBA is a Canadian pipeline company.
Probably bearish for trade between the US and Canada. https://t.co/wGXkoGFrQw
tweet